NCT03025893 A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme Status UNKNOWN Phase PHASE2/PHASE3
NCT03020602 BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab Status COMPLETED Phase PHASE1
NCT03018288 Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM) Status TERMINATED Phase PHASE2
NCT03008148 Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM Status UNKNOWN Phase PHASE2/PHASE3
NCT02997423 Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM) Status COMPLETED Phase N/A
NCT02981940 A Study of Abemaciclib in Recurrent Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02977780 INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) Status RECRUITING Phase PHASE2
NCT02974738 A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02968940 Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma Status COMPLETED Phase PHASE2
NCT02942264 Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT02919332 Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma Status WITHDRAWN Phase N/A
NCT02910804 IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma Status UNKNOWN Phase EARLY_PHASE1
NCT02904525 Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model Status UNKNOWN Phase NA
NCT02903069 Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer Status COMPLETED Phase PHASE1
NCT02902757 FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma Status COMPLETED Phase NA
NCT02880410 Feasibility Study on LITT for Newly Diagnosed Glioblastoma Status TERMINATED Phase PHASE1